Clinical Trials Regulatory Science Black Woman Scientist Beta-Propiolactone Method mRNA Technology Infectious Diseases
Documents reveal Dr. Vinay Prasad countermanded about 30 FDA reviewers to narrow vaccine eligibility after deeming the COVID-19 threat diminished.